Piper Sandler & Co’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
Other funds holding NEO
CRC
FLAM
CAM
TAM
KIA
DCM
GIM
NC
Piper Sandler & Co's NEO Position: Q1 2015 in Review
Piper Sandler & Co sold out of NeoGenomics (NEO) in Q1 2015, closing a stake of 80,000 shares — an estimated $334K sold.
Piper Sandler & Co first reported a position in NEO in Q4 2014 and held it in 1 quarter. The position peaked at $334K in Q4 2014. 84 funds tracked by Wall St. Rank hold NEO as of Q1 2015.
- Piper Sandler & Co reported no remaining NeoGenomics position as of Q1 2015 after selling out during the quarter.
- Piper Sandler & Co sold 80,000 NeoGenomics shares in Q1 2015, an estimated $334K.
- Piper Sandler & Co first reported a position in NeoGenomics in Q4 2014 and held it in 1 quarter.
- Piper Sandler & Co's NeoGenomics position peaked at $334K in Q4 2014.
- 84 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2015.
Based on Piper Sandler & Co's 13F filing for Q1 2015, filed 15 May 2015.